VHIValhi, Inc.
Is the price fair?
Neither cheap nor expensive: modest expectations priced in, but at the top of its own P/E range.
Priced for a decline (~−10% a year). The price demands less than its three-year revenue growth of 3% a year, expectations look modest.
Expensive vs its own history: P/E 24.2 vs a 8.3 median over 27 quarters (+190% vs median).
Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.
What VHI's price assumes
Valhi, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 0.19× revenue.
Price / sales · no P/E: the last twelve months did not end in a profit
- Free cash flow yield
- 15%
Free cash flow yield · Chemicals median 14%
- Growth the price implies
- −9.6%
Growth the price implies · The price pays for −9.6% free cash flow growth a year for a decade; revenue has grown 3.4% a year over the last three.
- Price / book
- 0.40
Price / book · as of 2026-Q2
Details›
- Price / bookas of 2026-Q2
- 0.40
- EV / EBITas of 2026-Q2
- 10.1
- EV / salesas of 2026-Q2
- 0.37
- Free cash flow, trailing twelve months
- $63M
- Market capitalisation28.3 million shares, counted Jul 31, 2026
- $410M
- 3-year revenue growth
- +3.4%
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
What is it worth?
Today's price against what its own multiples, its cash flow and your growth assumption say it is worth.
Against its own past
Its multiples now against their own history, and how much of the price move came from earnings rather than the multiple.